Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma.
Saved in:
| Title: | Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma. |
|---|---|
| Authors: | Matoba Y; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Department of Obstetrics and Gynecology, Keio University School of Medicine, Shinjuku-ku, Tokyo, 160-8582, Japan., Zarrella DT; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Pooladanda V; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, 02115, USA., Azimi Mohammadabadi M; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, 02115, USA., Kim E; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Kumar S; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Xu M; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Qin X; Harvard T.H. Chan School of Public Health, Boston, MA, 02114, USA., Ray LJ; Department of Pathology, Massachusetts General Hospital, Boston, MA, 02114, USA., Devins KM; Department of Pathology, Massachusetts General Hospital, Boston, MA, 02114, USA., Kumar R; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Kononenko A; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Eisenhauer E; Harvard Medical School, Boston, MA, 02115, USA.; Division Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Veillard IE; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA., Yamagami W; Department of Obstetrics and Gynecology, Keio University School of Medicine, Shinjuku-ku, Tokyo, 160-8582, Japan., Hill SJ; Harvard Medical School, Boston, MA, 02115, USA.; Department of Medical Oncology and Division of Molecular and Cellular Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Sarosiek KA; Harvard T.H. Chan School of Public Health, Boston, MA, 02114, USA., Yeku OO; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Spriggs DR; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, 02114, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, 02114, USA., Rueda BR; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. brueda@mgh.harvard.edu.; Harvard Medical School, Boston, MA, 02115, USA. brueda@mgh.harvard.edu.; Division Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 02114, USA. brueda@mgh.harvard.edu. |
| Source: | British journal of cancer [Br J Cancer] 2024 May; Vol. 130 (9), pp. 1463-1476. Date of Electronic Publication: 2024 Mar 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
